Journal of Renal Surgery

Dr. John Albert St.Cyr is Chief Medical Officer for RCRI, Inc. (Minneapolis, MN), and ImmuMed, Inc. (Minneapolis, MN). Dr. Albert St.Cyr a cardiovascular surgeon, received his B.A., M.S., M.D., and Ph.D. degrees from the University of Minnesota, Minneapolis, MN. Dr. Albert St.Cyr completed his general surgical training at the University of Minnesota and completed his cardiovascular surgical fellowship training at the University of Colorado Health Sciences Center in Denver, CO. Dr. St.Cyr has extensive research credentials, is widely published, has received numerous research grants, has numerous patents in various fields of interest, and has presented at many medical/surgical conferences/meetings. Dr. St. Cyr has consulted for many medical companies, such as a surgical/medical consultant for Medtronic, Inc. (Physiological Research Laboratories, a facility of Medtronic, Inc., Minneapolis, MN), a medical/surgical consultant for NAMSA/Integra, Inc. (Minneapolis, MN). Dr. St. Cyr is a member of numerous scientific research, medical, and surgical societies. His research interests include Congenital heart surgery, Congenital heart disease, Myocardial metabolism, Adenine nucleotides, Dialysis and Stem cell research.

Dr. Armin Pycha is a Chairman of Department of Urology at Sigmund Freud University Medical School at Austria. Dr. Armin Pycha studied medicine at Innsbruck University Medical School and graduated 1987. He specialized in Urology at the University of Vienna in 1996 where he also qualified as a professor in 1998. Since April 2000 he is Head of Department of Urology at the Central Hospital of Bolzano, Italy. As of November 2016 he is chairman for Urology at the Sigmund Freud University Medical School in Vienna, Austria. He is member of several international associations of Urology and examiner of the European Board of Urology. His main fields of expertise are Uro oncology, Pediatric Urology and Reconstructive Urology.

Dr. Saeid Mordechai Nosrati is a Associate Professor of Department of Medicine at University of Southern California, and and Medical Director of the CKD program and the Renal, Hypertension and Transplant Clinic at the LAC+USC. He attended medical school at the State University of New York in Brooklyn (1983-1987). After completing an internship and residency program at the Albert Einstein School of Medicine at Bronx, NY,(1987-2000), Dr. Nosrati was awarded a nephrology fellowship at Beth Israel Hospital/Harvard Medical School in Boston, MA. After completing his fellowship, Dr. Nosrati joined the Keck-USC School of Medicine in Los Angeles, CA in 1992 as an Assistant Professor of Medicine. Dr. Nosrati has also served as Medical Director of the Peritoneal Dialysis Program and Home Hemodialysis Program at the USC Dialysis Center and has been an attending physician at the CAPD Clinic, USC Outpatient Dialysis, Medicine Ward and Renal Ward at the LAC+USC Medical Center. Dr. Nosrati is actively involved in a number of bench research as well as clinical research in advancing kidney dialysis, liver dialysis and providing a support system for the MOF/MODS multisystem failures using advanced technologies. In addition he has been actively conducting major pharmaceutical sponsored phase II-IV clinical trials in hypertension, anemia, iron, secondary hyperparathyroidism etc.

Dr. Mony Fraer is an Associate Professor at University of Iowa Hospitals & Clinics. He received his MD from Grigore T Popa School of Medicine, University of Medicine & Pharmacy, Romania. Dr. Mony areas of research includes pivotal study to assess the safety and efficacy of a Selective Cytopheretic Device (SCD) in patients with Acute Kidney Injury, Study of Diabetic Nephropathy With Atrasentan and Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the clinical diagnosis of diabetic kidney disease. The clinical part of Dr. Mony work involves all aspects of care for patients with kidney diseases (including transplant, kidney stones, hypertension and dialysis) both in an inpatient (at all 3 hospitals in the Iowa City area) and outpatient setting; and he also continue to have a general internal medicine inpatient exposure. From an administrative perspective Dr. Mony has been the medical director for dialysis at University of Iowa since 2015; in this role, he is responsible for the quality and safety, staff education and other aspects of the 7 dialysis units owned by the University; leadership skills in this job involve communication, negotiations across departments and with senior leadership.

Prof. Emil Ceban is a professor of Department of Urology and Surgical Nephrology at State University of Medicine and Pharmacy, Moldova. He received hid PhD from State University of Medicine and Farmacy in 1997. Prof. Emil research interests include Urology, andrology, urolithiasis, urinary tract infections, chronic pyelonephritis, surgical treatment, open surgery. Prof. Emil is also a President of Board of Attestation and Evaluation of Urologists.

Dr. Yuanyuan Zhang is a Director of tissue therapy and assistant professor in the Wake Forest Institute for Regeneration Medicine (WFIRM) at Wake Forest University, USA. He received his PhD from University of Lausanne in Switzerland. Dr. Yuanyuan has conducted research in stem cell, cell therapy, tissue engineering, biomaterials, and regenerative medicine in andro-urology for more than 20 years. Dr. Yuanyuan was the first to demonstrate that stem cells exist in urine and that those cells (urine derived stem cells, USCs), with self-renewal and multipotent capacity, have a number of potential applications in cell-based therapy in treatment of renal insufficiency, graft rejection after renal transplantation, interstitial cystitis, urinary incontinence, erectile dysfunction, or lower urinary tract reconstruction. In addition, Dr. Yuanyuan is able to isolate, culture and characterize stem cells from other body fluids, such as breast milk, amniotic fluid, joint synovial fluid and menstrual blood, for potential use in various tissue repair or diagnosis of the diseases in the relative tissues.